News on urine-based diagnostic testing.
Pacific Edge Ramps up Clinical Utility Studies, Commercial Efforts Behind Bladder Cancer Test
The New Zealand-based diagnostics firm is hoping the coming year will be a tipping point toward new guideline inclusion and broader adoption.
CARB-X Awards MicrobeDx Up To $3.5M
The award will go toward the development of MicrobeDx's technology for detecting the presence of bacteria in clinical urine specimens and to which antibiotics they are susceptible.
The firm has partnered with the University of Surrey to validate and potentially commercialize a test that detects mRNA biomarkers from patient urine samples.
Investment Banks Upgrade Quidel Shares on Acquisition of Alere Assets
Canaccord and William Blair also increased their price targets on Quidel's shares, following its acquisition of certain Alere assets and assays.
Streck, Nordic BioSite Ink Distribution Deal
Streck and Nordic BioSite have signed a distribution agreement for Streck's full portfolio of cell stabilization, molecular, and core products.